A Study of R-mini-MCOP in the Treatment of Elderly, Previously Untreated DLBCL

NCT06921044 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG: R-miniMCOP:Rituximab / Mitoxantrone Liposome / Cyclophosphamide / Vincristine / Prednisone

Sponsor

Xiaohui He

Collaborators

[object Object]